| Oct 5 |
This Healthcare Growth Stock Could Be a Steal of a Deal Right Now
|
| Oct 4 |
Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m
|
| Oct 2 |
Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today
|
| Oct 2 |
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
|
| Oct 2 |
These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer
|
| Sep 22 |
CRISPR Therapeutics (NASDAQ:CRSP) shareholders have endured a 59% loss from investing in the stock three years ago
|
| Sep 21 |
3 Dirt Cheap Stocks to Buy Right Now
|
| Sep 19 |
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
|
| Sep 19 |
Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?
|
| Sep 18 |
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
|
